Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Intraoral vs Transcutaneous Botox for Masseter Myofascial Pain
NCT05673655Phase 2Unknown
- Sponsor
- Fayoum University
- Start
- Dec 2022
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in myofascial pain syndrome (MPS), sponsored by Fayoum University. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT05673655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05673655.